Pharma R&D & Clinical Services · Indirect
Monitoring · monthlyProcurement Category Intelligence
Carcinogenicity Studies
Overview
Market size
$6.0B
global, USD
CAGR
7.2%
base to forecast
Buyer power
-1.8
supplier-favoured
Suppliers
7
tracked players
Signals
12
6 high severity
Market outlook
2031$8.5B
What changed
Demand by region
North America demand45%
Europe demand30%
Asia Pacific demand18%
Rest of world demand7%
share of global demandtotal 100%
Cost drivers
Labor and specialized scientific personnel40%
Purpose bred rodent models and cellular feedstocks25%
Facility operations and specialized bioassay equipment15%
Reference carcinogens and chemical reagents10%
Regulatory compliance and quality assurance10%
share of delivered cost (analyst estimate)